लोड हो रहा है...

Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial

BACKGROUND: Hybrid therapy is a promising first-line regimen for Helicobacter pylori (H. pylori) eradication. We evaluated a hybrid therapy, assessing the impact of antibiotic resistance on eradication outcome. METHODS: This was a prospective study that included 155 treatment-naïve patients diagnose...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Ann Gastroenterol
मुख्य लेखकों: Georgopoulos, Sotirios D., Papastergiou, Vasilios, Martinez-Gonzalez, Beatriz, Xirouchakis, Elias, Familias, Ioannis, Sgouras, Dionysis, Mentis, Andreas, Karatapanis, Stylianos
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Hellenic Society of Gastroenterology 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5825950/
https://ncbi.nlm.nih.gov/pubmed/29507467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2017.0221
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!